Claims for Patent: 10,953,073
✉ Email this page to a colleague
Summary for Patent: 10,953,073
Title: | XTEN conjugate compositions and methods of making same |
Abstract: | The present invention relates to extended recombinant polypeptide (XTEN) compositions, conjugate compositions comprising XTEN and XTEN linked to cross-linkers useful for conjugation to pharmacologically active payloads, methods of making highly purified XTEN, methods of making XTEN-linker and XTEN-payload conjugates, and methods of using the XTEN-cross-linker and XTEN-payload compositions. |
Inventor(s): | Schellenberger Volker, Podust Vladimir, Wang Chia-Wei, McLaughlin Bryant, Sim Bee-Cheng, Ding Sheng, Gu Chen |
Assignee: | Amunix Pharmaceuticals, Inc. |
Application Number: | US16133444 |
Patent Claims: |
Details for Patent 10,953,073
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | January 15, 1974 | 10,953,073 | 2038-09-17 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | December 27, 1984 | 10,953,073 | 2038-09-17 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | February 15, 1985 | 10,953,073 | 2038-09-17 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | February 16, 1990 | 10,953,073 | 2038-09-17 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |